Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 4576 AL 4590

Proteomic analysis of protein homeostasis and aggregation

Laskowska E, Kuczyńska-Wiśnik D, Lipińska B.

J Proteomics. 2019 Apr 30;198:98-112. doi: 10.1016/j.jprot.2018.12.003. Epub 2018 Dec 6.

Behind the wheel safety in palliative care: a literature review

Howard M, Ramsenthaler C.

BMJ Support Palliat Care. 2019 Sep;9(3):255-258. doi: 10.1136/bmjspcare-2018-001639. Epub 2018 Dec 6.

Understanding cellular glycan surfaces in the central nervous system

Iqbal S, Ghanimi Fard M, Everest-Dass A, Packer NH, Parker LM.

Biochem Soc Trans. 2019 Feb 28;47(1):89-100. doi: 10.1042/BST20180330. Epub 2018 Dec 17.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Reilmann R, McGarry A, Grachev ID, Savola JM, Borowsky B, Eyal E, Gross N, Langbehn D, Schubert R, Wickenberg AT, Papapetropoulos S, Hayden M, Squitieri F, Kieburtz K, Landwehrmeyer GB; European Huntington's Disease Network; Huntington Study Group investigators.

Lancet Neurol. 2019 Feb;18(2):165-176. doi: 10.1016/S1474-4422(18)30391-0. Epub 2018 Dec 15.

Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies

Elfawy HA, Das B.

Life Sci. 2019 Feb 1;218:165-184. doi: 10.1016/j.lfs.2018.12.029. Epub 2018 Dec 20.

Versatility of fuzzy logic in chronic diseases: A review

Thukral S, Rana V.

Med Hypotheses. 2019 Jan;122:150-156. doi: 10.1016/j.mehy.2018.11.017. Epub 2018 Nov 27.

Regulation of P2X7 receptor expression and function in the brain

Jimenez-Mateos EM, Smith J, Nicke A, Engel T.

Brain Res Bull. 2019 Sep;151:153-163. doi: 10.1016/j.brainresbull.2018.12.008. Epub 2018 Dec 26.

Recent advances in the therapeutic development for Huntington disease

Mestre TA.

Parkinsonism Relat Disord. 2019 Feb;59:125-130. doi: 10.1016/j.parkreldis.2018.12.003. Epub 2018 Dec 12.

Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates

Niethammer M, Eidelberg D.

Int Rev Neurobiol. 2019;144:143-184. doi: 10.1016/bs.irn.2018.10.004. Epub 2018 Nov 28.

Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review

Schirinzi T, Garone G, Travaglini L, Vasco G, Galosi S, Rios L, Castiglioni C, Barassi C, Battaglia D, Gambardella ML, Cantonetti L, Graziola F, Marras CE, Castelli E, Bertini E, Capuano A, Leuzzi V.

Parkinsonism Relat Disord. 2019 Apr;61:19-25. doi: 10.1016/j.parkreldis.2018.11.019. Epub 2018 Nov 16.

Manganese Enhanced MRI for Use in Studying Neurodegenerative Diseases

Saar G, Koretsky AP.

Front Neural Circuits. 2019 Jan 7;12:114. doi: 10.3389/fncir.2018.00114. eCollection 2018.

Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation

Weber J, Frings L, Rijntjes M, Urbach H, Fischer J, Weiller C, Meyer PT, Klebe S.

Front Neurol. 2019 Jan 9;9:1168. doi: 10.3389/fneur.2018.01168. eCollection 2018.

Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

Niu X, Chen J, Gao J.

Asian J Pharm Sci. 2019 Sep;14(5):480-496. doi: 10.1016/j.ajps.2018.09.005. Epub 2018 Oct 22.

Subtle Imaging Findings Aid the Diagnosis of Adolescent Hereditary Spastic Paraplegia and Ataxia

Wagner F, Titelbaum DS, Engisch R, Coskun EK, Waugh JL.

Clin Neuroradiol. 2019 Jun;29(2):215-221. doi: 10.1007/s00062-018-0665-5. Epub 2018 Jan 29.

Complete elimination of a pathogenic homoplasmic mtDNA mutation in one generation

Brady L, Sadikovic B, Rupar CA, Tarnopolsky MA.

Mitochondrion. 2019 Mar;45:18-21. doi: 10.1016/j.mito.2018.01.010. Epub 2018 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias